Sadones, Océane
Kramarska, Eliza
Laverde, Diana
Berisio, Rita
Huebner, Johannes
Romero-Saavedra, Felipe
Funding for this research was provided by:
Klinikum der Universität München
Article History
Received: 29 February 2024
Accepted: 15 July 2024
First Online: 27 July 2024
Declarations
:
: Development of rabbit sera was performed by the company BioGenes GmbH in Berlin (Germany), in compliance with German guidelines and animal welfare regulations from the European Union, for housing, immunizing, and collecting serum samples. The study was approved by the Institutional Review Board National Institutes of Health (NIH)/ Office of Laboratory Animal Welfare (OLAW) (identifier A5755-01, Approved 1 June 2017).
: Not applicable.
: The authors declare no competing interests.